Back to search results

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Abroad (travel likely)RecruitingPHASE2

Conditions

Stage I Testicular Seminoma · Stage I Testicular Nonseminomatous Germ Cell Tumor · Gastrointestinal Stromal Tumors · Ovarian Germ Cell Tumor · Adenocarcinoma, Clear Cell · Borderline Ovarian Tumor · Sex Cord-Stromal Tumor · Mucinous Adenocarcinoma of Ovary · Carcinoma, Small Cell · Carcinosarcoma, Ovarian · Serous Tumor of Ovary · Glioma · Neuroendocrine Tumors · Aggressive Fibromatosis of Abdominal Wall (Disorder)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU Amiens, Amiens, France

    Contact: Study coordinator (Guillaume BONNET) · bonnet.guillaume@chu-amiens.fr
    Contact: Principal Investigator (Guillaume BONNET)
    Mathieu BOONE, MD (Sub-investigator)

  • Centre François Baclesse, Caen, France

    Contact: Study coordinator (François GERNIER) · f.gernier@baclesse.unicancer.fr
    Contact: Principal Investigator (François GERNIER)

  • Centre Oscar Lambret, Lille, France

    Contact: Study coordinator (Laurence ROTSAERT) · l-rotsaert@o-lambret.fr
    Contact: Principal Investigator (Laurence ROTSAERT)
    Nicolas PENEL, MD (Sub-investigator)
Study leads

  • PENEL Nicolas, MD, PhD

    Principal Investigator

    Centre Oscar Lambret

View source on ClinicalTrials.gov(opens in a new tab)